Eithne Costello

Development of Multiple Reaction Monitoring techniques for the quantification of biomarkers of pancreatic cancer

John F. Timms, Elliott, Claire Jenkinson, 2011 .

Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma.

Fiona Campbell, Eithne Costello, Masanori Akada, 2005, Gastroenterology.

Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk

Krzysztof Jamroziak, Ugo Boggi, Pavel Soucek, 2016, Oncotarget.

Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy

Fiona Campbell, Andrew Owen, Eithne Costello, 2011, Molecular Cancer.

Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial.

John R. Mackey, Fiona Campbell, David Goldstein, 2014, Journal of the National Cancer Institute.

Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis

Eithne Costello, Ekaterini Blaveri, Benoit Terris, 2004, International journal of cancer.

Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent

Eithne Costello, Benoit Terris, Eithne Costello, 2003, The Journal of pathology.

Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21

Alison P. Klein, Nan Hu, Peter Kraft, 2016, Oncotarget.

Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer

Yusuke Nakamura, Nan Hu, Peter Kraft, 2014, Nature Genetics.